Phase I trial of personalized AI-identified TCR-transduced T cell therapy in advanced solid tumors.
Many of the challenges we address here were evident to the pioneers of medical decision analysis of the 1950s 7 and to scholars in subsequent decades 8-11 who conducted careful and creative studies of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results